Conference Coverage
Conference Coverage
Pushing LDL below 25 mg/dL with alirocumab safe ‘so far’
Key clinical point: LDL cholesterol levels below 25 mg/dL induced by a superpotent investigational lipid-lowering agent appear to be safe through...
Conference Coverage
Oxygen may make STEMI worse
Key clinical point: Supplemental oxygen therapy in normoxic patients with STEMI was associated with larger infarct size and more recurrent MIs and...
Conference Coverage
VIDEO: DAGR may prove to be safer alternative to glucocorticoids
Conference Coverage
Ospemifene’s effect more comprehensive than its FDA indication
Key clinical point: Ospemifene could be an effective treatment for a range of moderate to severe menopausal symptoms. Major finding: Ospemifine 60...
Conference Coverage
Simple risk score predicts dementia risk in type 2 diabetes
Key clinical point: It’s now readily possible to predict the 10-year dementia risk for individuals with type 2 diabetes.
Conference Coverage
More dialysis time didn’t translate into better quality of life
Key clinical point: A doubling of dialysis time didn’t reap any significant clinical benefits for patients. Major finding: After a year of...
Conference Coverage
Unintended pregnancies fewer with Mirena vs. copper IUD
Key clinical point: The adjusted risk of unintended pregnancy was 84% lower with levonorgestrel-releasing IUDs than with copper IUDs. Major...
Conference Coverage
Azathioprine, mycophenolate mofetil ‘equally ineffective’ for lupus nephritis
Key clinical point: Azathioprine and mycophenolate mofetil are comparable as long-term maintenance therapies in patients with lupus nephritis....
Conference Coverage
Plurality main factor in adverse ART outcomes
Key clinical point: Higher rates of some adverse outcomes after ART appear to be due to multiple births, not ART itself. Major finding: Adjusted...